Skip to main content
SpringerLink
Log in

PDE5 inhibitors associated with sensorineural hearing loss

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Liu W, et al. Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study. Pharmacoepidemiology and Drug Safety : 7 Mar 2018. Available from: URL: http://doi.org/10.1002/pds.4405

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PDE5 inhibitors associated with sensorineural hearing loss. Reactions Weekly 1694, 13 (2018). https://doi.org/10.1007/s40278-018-43415-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-43415-y

Search

Navigation